期刊文献+

2-(3-硝基亚苄基)乙酰乙酸2-甲氧乙酯的合成

Synthesis of 2-methoxyethyl 2-(3-nitrobenzylidene)acetoacetate
下载PDF
导出
摘要 改进了合成 2 - ( 3-硝基亚苄基 )乙酰乙酸 2 -甲氧乙酯的方法。对加料顺序、投料比、反应温度、反应时间等因素对标题化合物收率的影响进行了研究 ,结果表明 ,其最佳条件为先加间硝基苯甲醛和乙酰乙酸 2 -甲氧乙酯 ,后加催化剂浓硫酸 ,间硝基苯甲醛和乙酰乙酸 2 -甲氧乙酯物质的量之比为 1∶ 1 .6,反应时间为 4h,反应温度为 0℃。在上述最佳条件下 ,总收率可达 92 % ,标题化合物的质量分数可达 98%。 The technology of synthesizing 2-methoxyethyl 2-(3-nitrobenzylidene)acetoacetate was improved in this paper. The effect of adding order, ratio of m-nitrobenzaldehyde to 2-methoxyethyl acetoacetate, the condensing temperature and time on the yield of the title compound were also investigated. The result shows that the optimum conditions are as follows: m-nitrobenzaldehyde and 2-methoxyethyl acetoacetate should be added before the catalyst, the ratio of m-nitrobenzaldehyde to 2-methoxyethyl acetoacetate is 1∶1.6, the time is 4 h and the temperature, 0 ℃. Under the optimum conditions the total yield is 92% and the purity of the product is about 98%.
出处 《淮海工学院学报(自然科学版)》 CAS 2004年第2期51-53,共3页 Journal of Huaihai Institute of Technology:Natural Sciences Edition
基金 淮海工学院自然科学基金资助项目 ( Z2 0 0 3 0 0 8)
关键词 双乙烯酮 缩合 间硝基苯甲醛 合成 diketene condensation m-nitrobenzaldehyde synthesis
  • 相关文献

参考文献3

二级参考文献31

  • 1[1]Fujil S, Kameyama K, Husone M et al. Effect of cilnidipine, a novel dihydropyridine Ca2 + -channel antagonist, on N-type Ca2 + channel in rat dorsal root ganglion neurons. J Pharmacol Exp Ther, 1997;280(3) : 1184
  • 2[2]Minami J, Ishimitsu T, Kawano Y et al. Comparison of 24-hour blood pressure, heart rate, and autonomic nerve activity in hy pertensive patients treated with cilnidipine or nifedipine retard. J Cardiovasc Pharmacol, 1998;32(2) :331
  • 3[3]Saihara S, Sumio M, HosonoMetal. Effect of FRC 8653 (cilni dipine) on blood pressure changes during the cold pressor test. J pn Pharmacol Ther , 1993;21(suppl):271
  • 4[4]Yoshimoto R, Hashiguchi Y, Dohmoto H et al. Effects of a new dihydropyridine derivative, FRC-8653, on blood pressure in con scious spontaneously hypertensive rats. J Pharmacobiodyn, 1992;15:25
  • 5[5]Ikeda K, Honoso M, Iida H et al. Antihypertensive and cardio vascular profiles of a newly synthesized dihydropyridine derivative 2-methoxyethyl(E)-3-phenyl-2-propen-1yl( ± ) 1,4 dihydro 2,6-dimethyl-4-(3-nitrophenyl) pyridine-3,5 dicarboxylate ( FRC-8653). Pharmacometrics, 1992;44:433
  • 6[6]Hisayuki U, Hirohisa U ,Tomoyuki K et al. CilnIdipine: pre clinical profile and clinical evaluation. Cardovascular Drug Re views, 1999;17:341
  • 7[7]Watanable K, Hosono M, Hayashi Y. Hypotensive effect of in travenous administration of cilnidipine (FRC 8653) in conscious spontaneously hypertensive rats. Jpn Pharmacol Ther, 1995; 23:3201~7
  • 8[8]Hosono M, Dozen M, Hiruma T et al. Change in heart rate and plasma norepinephrine level of conscious spontaneously hyperten sive rats treated with cilnidipine (FRC-8653). Jpn Pharmacol Ther , 1995;23:3029
  • 9[9]Hosono M, Fujii S, Hiruma T et al. Inhibitory effect of cilnidip ine on vascular sympathetic neurotransmission and subsequent vasoconstriction in spontaneously hypertensive rats, Jpn J Pharmacol 1995;69: 127
  • 10[10]Hesse I, Johns E. The subtype of adrenoceptor involved in the neural control of renal tubular sodium reabsorption in the rabbit. J Physiol (Lond), 1984;352:527

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部